[1] Tsukamoto S, Ota S, Ohwada C,et al. Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation.Leuk Res Rep. 2013 Aug 13;2(2):67-69.
[2] 武汉医学院第一附属医院血液病研究所.白血病[M].武汉:湖北人民出版社,1979,5.
[3] O’Brien S, Berman E, Borghaei H ,et al. NCCN Clinical Practice Guidelines in Oncology:chronic myelogenous leukemia.J Natl Compr Canc Netw. 2009 Oct;7(9):984-1023.
[4] Alemán JO,Farooki A,Girotra M. Effects of tyrosine kinase inhibition on bone etabolism:untargeted consequences of targeted therapies .Endocr Relat Cancer,2014,8:21(3):247-259.
[5] E Steingrímsson, K J Moore, M L Lamoreux,et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nature Genetics. 1994,8:256-263.
[6] Soriano P, Montgomery C, Geske R,et al. Targeted disruption of the c-src protooncogene leads to osteopetrosis in mice. Cell.1991Feb22; 64(4) :693-702.